Bahrain Bay:Bahrain M42, an international leader in health powered by artificial intelligence, technology, and genomics, has announced plans to develop Mubadala Health Bahrain, a multidisciplinary healthcare facility in Bahrain Bay. This marks a new phase in M42's expansion within the Kingdom, aiming to enhance healthcare services for the local population.

According to Emirates News Agency, the announcement was made at the Abu Dhabi Future Health Summit, coinciding with the signing of a strategic agreement between M42 and Bahrain's Future Generation Reserve (FGR) fund. This agreement secures a location for the new seafront facility in Bahrain Bay.

Mubadala Health Bahrain will be M42's second healthcare facility in the country, emphasizing the group's commitment to expanding specialized care across the region. It will be developed through a joint venture with HealthVision, a Bahraini partner, and will offer services across 20 specialties, including six surgical inpatient specialties at its launch. These specialties will range from endocrinology and dentistry to precision medicine and genomics, demonstrating a transformative step in healthcare delivery in Bahrain.

The facility is expected to employ approximately 200 people, with a strong emphasis on Bahrainization to create skilled employment opportunities. It will support the development of local healthcare capabilities, reflecting M42's broader regional growth strategy of combining global clinical expertise with strong local partnerships.

The strategic placement of the facility in Bahrain Bay aligns with the area's diversification into high-value sectors and services, further establishing Bahrain as a destination for high-quality investments. Mubadala Health Bahrain aims to provide a trusted healthcare destination that aligns with Bahrain's national healthcare priorities, offering high-quality clinical expertise closer to patients.